chr1-22644031-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_172369.5(C1QC):āc.8T>Cā(p.Val3Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00048 in 1,590,898 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_172369.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QC | NM_172369.5 | c.8T>C | p.Val3Ala | missense_variant | 2/3 | ENST00000374640.9 | NP_758957.2 | |
C1QC | NM_001114101.3 | c.8T>C | p.Val3Ala | missense_variant | 2/3 | NP_001107573.1 | ||
C1QC | NM_001347619.2 | c.8T>C | p.Val3Ala | missense_variant | 2/3 | NP_001334548.1 | ||
C1QC | NM_001347620.2 | c.-87+317T>C | intron_variant | NP_001334549.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QC | ENST00000374640.9 | c.8T>C | p.Val3Ala | missense_variant | 2/3 | 1 | NM_172369.5 | ENSP00000363771 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 151744Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00111 AC: 233AN: 209392Hom.: 1 AF XY: 0.00149 AC XY: 168AN XY: 112558
GnomAD4 exome AF: 0.000503 AC: 724AN: 1439034Hom.: 10 Cov.: 31 AF XY: 0.000708 AC XY: 505AN XY: 713302
GnomAD4 genome AF: 0.000257 AC: 39AN: 151864Hom.: 0 Cov.: 32 AF XY: 0.000391 AC XY: 29AN XY: 74250
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | C1QC: BP4 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
C1Q deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Jan 27, 2022 | C1QC NM_172369.4 exon 2 p.Val3Ala (c.8T>C): This variant has been reported in the literature in at least 1 individual with very early onset inflammatory bowel disease (VEO-IBD) (Kelsen 2015 PMID:26193622). This variant is present in 0.8% (218/25750) of South Asian alleles including 1 homozygote in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-22970524-T-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:1164154). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at